Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Rheumatology
•
Methotrexate
•
General Rheumatology
•
Nephrology
At what level of renal impairment do you typically reduce or avoid methotrexate in your rheumatology practice?
Related Questions
How would you advise a CKD patient who asks about oral NSAIDs for management of chronic pain if they have a contraindication to taking acetaminophen?
What is your approach to methotrexate use (or avoidance) in patients with varying MTHFR mutations?
How would you approach management of retroperitoneal fibrosis causing ureteral compression that has already caused irreversible loss of kidney function?
How do you approach prescribing analgesics for osteoarthritis related pain in patients with comorbidities, particularly given new evidence that even acetaminophen is associated with increased risk of GI complications (bleeding, peptic ulcer disease), heart failure and CKD?
How do you counsel patients about the potential malignancy risk associated with traditional DMARDs?
How do you counsel patients on use of creatinine monohydrate supplementation during a hospitalization for acute rhabdomyolysis from intense physical training?
What is your approach to diagnosing and managing methotrexate-induced alopecia?
Do you always get a baseline chest xray in patients who will be starting methotrexate?
Do you have to extend treatment for acute Lyme disease if a patient is on high dose steroids for another indication?
What is your approach to explaining the role of the microbiome to patients with inflammatory arthritis?
